Elisabetta Fenocchio

candiolo cancer institute fpo irccs

H指数:20

被引数:2,170

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real-world study

胆道癌患者接受化疗免疫疗法后的预后分层：一项回顾性多中心真实世界研究

Cancer

IF5.1

2026-09-160

PRE

Mara Persano MD; Andrea Casadei-Gardini MD; Lorenzo Fornaro MD; Tomoyuki Satake MD, PhD; Oluseyi Abidoye MD; Federica Lo Prinzi MD; Lorenzo Antonuzzo MD; Jin Won Kim MD, PhD; Francesca Bergamo MD; Melanie Bathon MD; Anna Saborowski MD; Tiziana Pressiani MD; Caterina Vivaldi MD; Ilario Giovanni Rapposelli MD; Frederik Peeters MD; Chiara Braconi MD, PhD; David J. Pinato MD, PhD; Emiliano Tamburini MD; Monica Niger MD; Stefano Tamberi MD; Florian Castet MD; Monica Verrico MD; Alessandro Parisi MD; Nuno Couto MD; Hong Jae Chon MD, PhD; Angela Lamarca MD, PhD; Guido Giordano MD; Fabian Finkelmeier MD; Ester Oneda MD; Antonio Avallone MD; Lukas Perkhofer MD; Il Hwan Kim MD, PhD; Ingrid Garajova MD; Salvatore Corallo MD; Elisabetta Fenocchio MD; Emanuela Dell’Aquila MD; Chiara Pirrone MD; Lorenzo Lucidi MD; Giulia Tesini MD; Elena Valenzi MD; Anna Diana MD; Changhoon Yoo MD, PhD; Marta Schirripa MD; Vincenzo Formica MD; Maria Grazia Rodriquenz MD; Mario Scartozzi MD; Jorge Adeva MD; Michele Ghidini MD; Gerald W. Prager MD; Giuseppe Aprile MD; Gian Paolo Spinelli MD; Su Yung-Yeh MD, PhD; Stephen L. Chan MD; Masafumi Ikeda MD; Tanios Bekaii-Saab MD; Jessica Lucchetti MD; Daniele Lavacchi MD; Minsu Kang MD; Rita Balsano MD; Francesca Salani MD; Silvia Camera MD; Gianluca Masi MD; Sara Lonardi MD; Arndt Vogel MD, PhD; Lorenza Rimassa MD; Margherita Rimini MD

Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy

胆道癌患者接受化疗免疫疗法治疗后不良事件预测作用的全球人群研究

Cancers

IF4.4

2026-09-100

Linda Bartalini; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Arndt Vogel; Angela Lamarca; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Jeroen Dekervel; Chiara Braconi; David James Pinato; Emiliano Tamburini; Chiara Carlotta Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell’Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Changhoon Yoo; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Yung-Yeh Su; Stephen L. Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Andrea Pretta; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Lorenzo Fornaro; Andrea Casadei-Gardini; Lorenza Rimassa

Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World Setting

根据TOPAZ-1研究入组标准评估顺铂、吉西他滨和度伐利尤单抗的疗效：一项真实世界环境下的全球性大规模分析

International Journal of Cancer

IF4.7

2026-08-160

PRE

Federica Lo Prinzi; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Frederik Peeters; Chiara Braconi; David J. Pinato; Emiliano Tamburini; Chiara Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Angela Lamarca; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell'Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Yoo Changhoon; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Su Yung-Yeh; Stephen Lam Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Guido Giordano; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Arndt Vogel; Lorenzo Fornaro; Lorenza Rimassa; Andrea Casadei-Gardini

Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real-World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab

探索系统性治疗后的手术治疗在局部晚期胆道癌中的作用：来自接受顺铂、吉西他滨和度伐利尤单抗治疗的大型回顾性跨国真实世界队列的结局

International Journal of Cancer

IF4.7

2026-08-150

PRE

Margherita Rimini; Angela Lamarca; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Arndt Vogel; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Frederik Peeters; Chiara Braconi; David J. Pinato; Emiliano Tamburini; Chiara Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell'Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Yoo Changhoon; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Su Yung-Yeh; Stephen L. Chan; Iakov Bolnykh; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Massimo Giuseppe Viola; Silvia Bozzarelli; Mara Persano; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Francesca Ratti; Lorenzo Fornaro; Lorenza Rimassa; Andrea Casadei-Gardini

Post-surgery level of circulating DNA in stage III colon cancer patients: Impact on the reliability of minimal residual disease detection

术后循环DNA水平在III期结直肠癌患者中的变化：对微小残留病灶检测可靠性的影响

International Journal of Cancer

IF4.7

2026-02-110

OAAI

Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers

度伐利尤单抗在晚期胆道癌中的应用：来自多个国际中心大型患者队列的真实世界数据

LIVER INTERNATIONAL

IF5.2

2025-11-120

OAAI

Rimini, Margherita; Fornaro, Lorenzo; Ikeda, Masafumi; Abidoye, Oluseyi; Lucchetti, Jessica; Antonuzzo, Lorenzo; Kim, Jin Won; Nichetti, Federico; Saborowski, Anna; Pressiani, Tiziana; Vivaldi, Caterina; Rapposelli, Ilario Giovanni; Peeters, Frederik; Braconi, Chiara; Pinato, David J.; Tamburini, Emiliano; Pircher, Chiara; Tamberi, Stefano; Castet, Florian; Verrico, Monica; Parisi, Alessandro; Couto, Nuno; Chon, Hong Jae; Martirena, Andrea; Lamarca, Angela; Landriscina, Matteo; Fimkelmeier, Fabian; Oneda, Ester; Avallone, Antonio; Dell'Aquila, Emanuela; Perkhofer, Lukas; Kim, Il Hwan; Pinto, Cidalia Maria de Sousa; Garajova, Ingrid; Kang, Beodeul; Corallo, Salvatore; Fenocchio, Elisabetta; Farinea, Giovanni; Pastorino, Alessandro; Diana, Anna; Changhoon, Yoo; Schirripa, Marta; Rodriquenz, Maria Grazia; Scartozzi, Mario; Zumstein, Lucrezia; Ghidini, Michele; Prager, Gerald W.; Aprile, Giuseppe; Spinelli, Gian Paolo; Yung-Yeh, Su; Chan, Stephen; Warmington, Emily; Lancianese, Alessia; Bekaii-saab, Tanios; Lavacchi, Daniele; Kang, Minsu; Lonardi, Sara; Vogel, Arndt; Prete, Alessandra Anna; Bozzarelli, Silvia; Salani, Francesca; Persano, Mara; Masi, Gianluca; Balsano, Rita; Niger, Monica; Camera, Silvia; Passeri, Laura; Ferrara, Michele; Satake, Tomoyuki; Rimassa, Lorenza; Casadei-Gardini, Andrea

Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO

帕尼单抗（panitumumab）再治疗随后使用瑞戈非尼（regorafenib）与相反顺序在RAS和 BRAF野生型循环肿瘤DNA的化学耐药性转移性结直肠癌患者中的比较：GONO进行的PARERE研究

Annals of Oncology

IF65.4

2025-10-180

OAAI

Precision oncology in gastric cancer: Shaping the future of personalized treatment

胃癌中的精准肿瘤学：塑造个性化治疗的未来

Cancer Treatment Reviews

IF10.5

2025-10-160

OAAI

Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial

基因组匹配疗法在晚期实体瘤中的应用：随机II期ROME试验

Nature Medicine

IF50

2025-09-290

OAAI

Paolo Marchetti; Giuseppe Curigliano; Mauro Biffoni; Sara Lonardi; Simone Scagnoli; Lorenzo Fornaro; Valentina Guarneri; Ugo De Giorgi; Paolo Antonio Ascierto; Giovanni Blandino; Giulia D’Amati; Massimo Aglietta; Chiara Cremolini; Pierfranco Conte; Edoardo Crimini; Maurizio Ceracchi; Simona Pisegna; Sofia Verkhovskaia; Roberto Bordonaro; Sergio Bracarda; Giovanni Butturini; Lucia Del Mastro; Andrea DeCensi; Agnese Fabbri; Elisabetta Fenocchio; Stefania Gori; Giulio Metro; Annamaria Pessino; Daniele Pozzessere; Fabio Puglisi; Stefano Tamberi; Alberto Zambelli; Donatella Marino; Ettore Capoluongo; Federico Cappuzzo; Bruna Cerbelli; Giuseppe Giannini; Umberto Malapelle; Federica Mazzuca; Marianna Nuti; Giancarlo Pruneri; Maurizio Simmaco; Lidia Strigari; Giuseppe Tonini; Nello Martini; Andrea Botticelli

Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancer

III期结肠癌患者随访中发现与疾病进展和化疗无关的术后后遗症

EBIOMEDICINE

IF10.8

2024-10-010

OAAI

Mirandola, Alexia; Kudriavtsev, Andrei; Munoz, Catalina Isabel Cofre; Navarro, Raquel Comas; Macagno, Marco; Daoud, Saidi; Sanchez, Cynthia; Pastor, Brice; Pisareva, Ekaterina; Marin, Mireia Sanchis; Ruiz, Javier Gonzalo; Piris, Alejandro; Rodriguez, Ariadna Garcia; Gonzalez, Nadia Saoudi; Vivancos, Ana; Quara, Virginia; Mellano, Alfredo; Borghi, Felice; Corti, Giorgio; Marchio, Caterina; Sapino, Anna; Bartolini, Alice; Crisafulli, Giovanni; Bardelli, Alberto; Di Maio, Massimo; Lossaint, Gerald; Frayssinoux, Florence; Crapez, Evelyne; Ychou, Marc; Soler, Ramon Salazar; Fenocchio, Elisabetta; Calotti, Paula X. Fernandez; Mazard, Thibault; Vivas, Cristina Santos; Elez, Elena; Di Nicolantonio, Federica; Thierry, Alain R.

CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches

CTC衍生的胰腺癌模型可作为研究工具，适用于精准医学方法

CELL REPORTS MEDICINE

IF10.6

2024-09-010

OAAI

Rethinking colorectal cancer prognosis: beyond microsatellite status

LANCET GASTROENTEROLOGY & HEPATOLOGY

IF38.6

2024-05-010

PRE

Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset

ESMO OPEN

IF8.3

2024-04-014

OAAI

Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of stage III colon cancer patients

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Kudriavtsev, Andrei; Mirandola, Alexia; Munoz, Catalina I. Cofre; Navarro, Raquel Comas; Macagno, Marco; Pastor, Brice; Pisareva, Ekaterina; Marin, Mireia Sanchis; Ruiz, Javier Gonzalo; Sapino, Anna; Bartolini, Alice; Di Maio, Massimo; Sanchez, Cynthia; Gricourt, Yann; Capdevila, Xavier; Lossaint, Gerald; Crapez, Evelyne; Ychou, Marc; Soler, Ramon Salazar; Fenocchio, Elisabetta; Calotti, Paula X. Fernandez; Cuvillon, Philippe; Mazard, Thibault; Vivas, Cristina Santos; Elez, Elez M.; Di Nicolantonio, Federica; Thierry, Alain R.

Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival

CLINICAL AND EXPERIMENTAL MEDICINE

IF3.5

2023-11-014

OAAI

The impact of preoperative nutritional screening, ERAS protocol, and mini-invasive surgery in surgical oncology: A multi-institutional SEM analysis of patients with digestive cancer

FRONTIERS IN NUTRITION

IF5.1

2023-03-163

OAAI

Lorenzon, Laura; Caccialanza, Riccardo; Casalone, Valentina; Santoro, Gloria; Delrio, Paolo; Izzo, Francesco; Tonello, Marco; Mele, Maria Cristina; Pozzo, Carmelo; Pedrazzoli, Paolo; Pietrabissa, Andrea; Fenu, Piero; Mellano, Alfredo; Fenocchio, Elisabetta; Avallone, Antonio; Bergamo, Francesca; Nardi, Maria Teresa; Persiani, Roberto; Biondi, Alberto; Tirelli, Flavio; Agnes, Annamaria; Ferraris, Renato; Quara, Virginia; Milanesio, Michela; Ribero, Dario; Rinaldi, Marilena; D'Elia, Paola; Rho, Maurizio; Cenzi, Carola; D'Ugo, Domenico

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

密码子特异性KRAS突变预测转移性结直肠癌中三氟尿苷/替匹拉西的生存益处

NATURE MEDICINE

IF50

2023-03-0244

OAAI

van de Haar, Joris; Ma, Xuhui; Ooft, Salo N.; van der Helm, Pim W.; Hoes, Louisa R.; Mainardi, Sara; Pinato, David J.; Sun, Kristi; Salvatore, Lisa; Tortora, Giampaolo; Zurlo, Ina Valeria; Leo, Silvana; Giampieri, Riccardo; Berardi, Rossana; Gelsomino, Fabio; Merz, Valeria; Mazzuca, Federica; Antonuzzo, Lorenzo; Rosati, Gerardo; Stavraka, Chara; Ross, Paul; Rodriquenz, Maria Grazia; Pavarana, Michele; Messina, Carlo; Iveson, Timothy; Zoratto, Federica; Thomas, Anne; Fenocchio, Elisabetta; Ratti, Margherita; Depetris, Ilaria; Cergnul, Massimiliano; Morelli, Cristina; Libertini, Michela; Parisi, Alessandro; De Tursi, Michele; Zanaletti, Nicoletta; Garrone, Ornella; Graham, Janet; Longarini, Raffaella; Gobba, Stefania Maria; Petrillo, Angelica; Tamburini, Emiliano; La Verde, Nicla; Petrelli, Fausto; Ricci, Vincenzo; Wessels, Lodewyk F. A.; Ghidini, Michele; Cortellini, Alessio; Voest, Emile E.; Valeri, Nicola

Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features

结直肠癌中异质错配修复蛋白表达的独特模式揭示了不同程度的肿瘤突变负荷和独特的肿瘤微环境特征

MODERN PATHOLOGY

IF5.5

2023-02-0116

OAAI

Fluoropyrimidine-induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT)

ONCOLOGY REPORTS

IF3.9

2022-12-216

OAAI

Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer